| Bioactivity | Smilagenin acetate is a sapogenin derivative extracted from patent US20030004147A1. Smilagenin acetate increases the expression of acetylcholine m2 receptors and can be used for the research of dementia[1]. |
| Invitro | Smilagenin acetate increases the expression of m2 receptors on CHO cells transfected with DNA for the m2 receptor[1]. |
| Name | Smilagenin acetate |
| CAS | 4947-75-5 |
| Formula | C29H46O4 |
| Molar Mass | 458.67 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, sealed storage, away from moisture and light *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light) |
| Reference | [1]. Paul Barraclough, et al. 5-beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia. US20030004147A1. |
Smilagenin acetate
CAS: 4947-75-5 F: C29H46O4 W: 458.67
Smilagenin acetate is a sapogenin derivative extracted from patent US20030004147A1. Smilagenin acetate increases the exp
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.